4 Biotechs Ready to Kill the Market in 2018 Post author:Sam Post published:December 28, 2017 Post category:BioPharma A look at a few biotechs which should outperform the market in 2018: Source: BioSpace You Might Also Like Merit Medical Coughs Up $100M for Bard, BD's Biopsy Assets November 15, 2017 2 Drugmakers Seek to Block Arkansas from Using Their Drugs to Execute 7 Men April 13, 2017 Beleaguered Axovant Begins Cutting Jobs While Exiting CEO Gets $2.6M+ Severance Package February 14, 2018
Beleaguered Axovant Begins Cutting Jobs While Exiting CEO Gets $2.6M+ Severance Package February 14, 2018
